Stock TVTX TRAVERE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Travere Therapeutics, Inc.

Equities

TVTX

US89422G1076

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-17 pm EDT 		5-day change 1st Jan Change
6.06 USD -9.42% Intraday chart for Travere Therapeutics, Inc. -3.81% -32.59%
May. 15 Transcript : Travere Therapeutics, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 08:00 AM
May. 07 Canaccord Genuity Adjusts Price Target on Travere Therapeutics to $18 From $15, Maintains Buy Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
TRAVERE THERAPEUTICS, INC.
Bio Therapeutic Drugs
-9.42%-3.81%-32.59%-63.52%-68.12% 461M
Bullish
Bearish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. TVTX Stock
  4. Charts Travere Therapeutics, Inc.
  5. Comparison Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW